Cargando…

A Qualitative Study to Assess US Patient Preferences between new Transdermal System and Injectable Anabolic Therapies for Osteoporosis Treatment

MINI ABSTRACT: US patients with osteoporosis included in three focus groups identified efficacy, safety, cost, and convenience as important attributes of treatment when choosing between anabolic therapies with high stated preference for the solid Microstructured Transdermal System. OBJECTIVE: The cu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beaudart, Charlotte, Silverman, Stuart, Gold, Deborah T., Williams, Setareh A., Weiss, Rich, Hiligsmann, Mickael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer London 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979159/ https://www.ncbi.nlm.nih.gov/pubmed/35378644 http://dx.doi.org/10.1007/s11657-022-01075-z

Ejemplares similares

Impact of fractures on quality of life in patients with osteoporosis: a US cross-sectional survey
por: Gold, Deborah T., et al.
Publicado: (2019)

Effective communication regarding risk of fracture for individuals at risk of fragility fracture: a scoping review
por: Beaudart, Charlotte, et al.
Publicado: (2021)

Cost Effectiveness Analyses of Interventions for Osteoporosis in Men: A Systematic Literature Review
por: Li, Nannan, et al.
Publicado: (2023)

Correction to: Cost Effectiveness Analyses of Interventions for Osteoporosis in Men: A Systematic Literature Review
por: Li, Nannan, et al.
Publicado: (2023)

Experts’ preferences for sarcopenia outcomes: a discrete-choice experiment from a working group of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) in collaboration with the European Union of Geriatric Medicine Society (EUGMS)
por: Beaudart, Charlotte, et al.
Publicado: (2021)

The Value of a Patient-Level Modeling Approach and Need for Better Reporting in Economic Evaluations of Osteoporosis
por: Hiligsmann, Mickael, et al.
Publicado: (2020)

A Review of Patient Preferences for Osteoporosis Drug Treatment
por: Hiligsmann, Mickaël, et al.
Publicado: (2015)

Enhancing Public Participation in Public Health Offerings: Patient Preferences for Facilities in the Western Cape Province Using a Discrete Choice Experiment
por: Chiwire, Plaxcedes, et al.
Publicado: (2022)

Medication administration errors in the domain of infusion therapy in intensive care units: a survey study among nurses
por: Beaudart, Charlotte, et al.
Publicado: (2023)

Anabolic Therapies
por: Lane, Nancy E., et al.
Publicado: (2010)

Compliance and persistence with osteoporosis medications: A critical review of the literature
por: Silverman, Stuart, et al.
Publicado: (2010)

Osteoporosis medication profile preference: results from the PREFER‐US study
por: Weiss, Thomas W., et al.
Publicado: (2007)

Systematic literature review of the economic burden of spinal muscular atrophy and economic evaluations of treatments
por: Dangouloff, Tamara, et al.
Publicado: (2021)

Patients’ preferences for osteoporosis drug treatment: a discrete-choice experiment
por: Hiligsmann, Mickaël, et al.
Publicado: (2014)

Cost-Effectiveness of Emerging Treatments for Atopic Dermatitis: A Systematic Review
por: Heinz, Katja C., et al.
Publicado: (2023)

A review of anabolic therapies for osteoporosis
por: Lane, Nancy E, et al.
Publicado: (2003)

Anabolic Therapies in Osteoporosis and Bone Regeneration
por: Russow, Gabriele, et al.
Publicado: (2018)

Anabolic treatments for osteoporosis in postmenopausal women
por: Hassan, Neelam, et al.
Publicado: (2021)

Beliefs regarding COVID-19 vaccinations of young adults in the United Kingdom: An interview study applying the Integrated Change Model
por: van Bergen, Ilja, et al.
Publicado: (2022)

Patient Preferences in the Management of Hidradenitis Suppurativa: Results of a Multinational Discrete Choice Experiment in Europe
por: Willems, Damon, et al.
Publicado: (2023)

Anabolic therapy for osteoporosis: update on efficacy and safety
por: Bandeira, Leonardo, et al.
Publicado: (2022)

Economic Burden of Osteoporosis-Related Fractures in the US Medicare Population
por: Williams, Setareh A., et al.
Publicado: (2020)

Optimizing Sequential and Combined Anabolic and Antiresorptive Osteoporosis Therapy
por: Leder, Benjamin Z
Publicado: (2018)

Challenges in osteoporosis awareness and management: results from a survey of US postmenopausal women
por: Lewiecki, E. Michael, et al.
Publicado: (2019)

FRI682 Cost Effectiveness Of Four Treatment Approaches For US Women And Men At Very High Risk Of Osteoporotic Fractures
por: Hiligsmann, Mickael, et al.
Publicado: (2023)

Understanding patients’ preferences for osteoporosis treatment: the impact of patients’ characteristics on subgroups and latent classes
por: Cornelissen, D., et al.
Publicado: (2019)

An Updated Systematic Review of Cost-Effectiveness Analyses of Drugs for Osteoporosis
por: Li, Nannan, et al.
Publicado: (2020)

Osteoporosis and sarcopenia: two diseases or one?
por: Reginster, Jean-Yves, et al.
Publicado: (2016)

Romosozumab: a novel bone anabolic treatment option for osteoporosis?
por: Kerschan-Schindl, Katharina
Publicado: (2019)

Therapeutic Anabolic and Anticatabolic Benefits of Natural Chinese Medicines for the Treatment of Osteoporosis
por: He, Jianbo, et al.
Publicado: (2019)

Analysis of Serum Proteome after Treatment of Osteoporosis with Anabolic or Antiresorptive Drugs
por: del Real, Alvaro, et al.
Publicado: (2022)

Recommendations for the conduct of economic evaluations in osteoporosis: outcomes of an experts’ consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the US branch of the International Osteoporosis Foundation
por: Hiligsmann, M., et al.
Publicado: (2018)

Rational polyelectrolyte nanoparticles endow preosteoclast-targeted siRNA transfection for anabolic therapy of osteoporosis
por: Zhang, Zheng, et al.
Publicado: (2023)

Bone-targeted pH-responsive cerium nanoparticles for anabolic therapy in osteoporosis
por: Dou, Ce, et al.
Publicado: (2021)

Denosumab for Elderly Men with Osteoporosis: A Cost-Effectiveness Analysis from the US Payer Perspective
por: Silverman, Stuart, et al.
Publicado: (2015)

Design of a transdermal formulation containing raloxifene nanoparticles for osteoporosis treatment
por: Nagai, Noriaki, et al.
Publicado: (2018)

Psychometric properties of the osteoporosis assessment questionnaire (OPAQ) 2.0: results from the multiple outcomes of raloxifene evaluation (MORE) study
por: Shen, Wei, et al.
Publicado: (2014)

Real-world evidence: new opportunities for osteoporosis research. Recommendations from a Working Group from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
por: Moon, Rebecca J., et al.
Publicado: (2023)

Combination therapy of anabolic and nonbisphosphonates antiresorptive agents for the treatment of osteoporosis: A meta-analysis
por: Lou, Shenghan, et al.
Publicado: (2017)

Antagonizing microRNA‐19a/b augments PTH anabolic action and restores bone mass in osteoporosis in mice
por: Taipaleenmäki, Hanna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7jmurtenf8u4dufq3i55mb75hv